6 results
Opioid Use Disorder Medications - Pharmacokinetics

Buprenorphine is a partial mu-opioid receptor agonist with low intrinsic activity,
Opioid Use Disorder Medications ... activity, high binding ... margin of safety in pharmacology ... Pharmacokinetics #Comparison ... #Table #Pharmacology
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
GLP-1 Agonists ... commonly used medications ... mistaken these medications ... #Pharmacology #Dosing ... Diabetes #DM2 #Endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... GLP-1 receptor agonist ... #pharmacology # ... comparison #table ... #endocrinology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
Dosing: 3 mg ... semaglutide, the same medication ... take any other medications ... semaglutide #Diabetes #Pharmacology ... #Endocrinology
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
Potassium-Binding ... aspiration #Potassium #Binding ... #Hyperkalemia #medications ... #pharmacology # ... table #comparison
Sedative-Hypnotic Drugs
Benzodiazepines:
 - Bind to specific GABAA receptor subunits at central nervous system (CNS) neuronal synapses
Antagonists: - Blocks binding ... 5-HT-Receptor Agonist ... Hypnotic #Drugs #medications ... #pharmacology # ... comparison #table